EXHIBIT 31

                                 CERTIFICATIONS

I, Stephen A. Levine, certify that:

     1.   I have reviewed this quarterly report on Form 10-QSB of Allergy
          Research Group, Inc. (the "registrant") for the quarter ended March
          31, 2007;
     2.   Based on my knowledge, this quarterly report does not contain any
          untrue statement of a material fact or omit to state a material fact
          necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this quarterly report;
     3.   Based on my knowledge, the financial statements, and other financial
          information included in this report, fairly present in all material
          respects the financial condition, results of operations and cash flows
          of the registrant as of, and for, the periods presented in this
          quarterly report;
     4.   I am responsible for establishing and maintaining disclosure controls
          and procedures (as defined in Exchange Act Rules 13a-15(e) and
          15d-15(e)) for the registrant and have:
               a)   Designed such disclosure controls and procedures, or caused
                    such disclosure controls and procedures to be designed under
                    my supervision, to ensure that material information relating
                    to the registrant, including its consolidated subsidiaries,
                    is made known to me by others within those entities,
                    particularly during the period in which this report is being
                    prepared;
               b)   Evaluated the effectiveness of the registrant's disclosure
                    controls and procedures and presented in this report my
                    conclusions about the effectiveness of the disclosure
                    controls and procedures, as of the end of the period covered
                    by this report based on such evaluation; and
               c)   Disclosed in this report any change in the registrant's
                    internal control over financial reporting that occurred
                    during the registrant's most recent fiscal quarter that has
                    materially affected, or is reasonably likely to materially
                    affect, the registrant's internal control over financial
                    reporting;
     5.   I have disclosed, based on my most recent evaluation of internal
          control over financial reporting, to the registrant's auditors and the
          audit committee of registrant's board of directors (or persons
          performing the equivalent functions):
               a)   All significant deficiencies and material weakness in the
                    design or operation of internal control over financial
                    reporting which are reasonably likely to adversely affect
                    the registrant's ability to record, process, summarize and
                    report financial information; and
               b)   Any fraud, whether or not material, that involves management
                    or other employees who have a significant role in the
                    registrant's internal control over financial reporting.

Date: May 15, 2007

/s/ Stephen A. Levine
- ---------------------------------------------------
Stephen A. Levine
Chief Executive Officer and Chief Financial Officer